In contrast to our previous studies on antibodies against light and medium subunits of neurofilaments [12], [13], intrathecal synthesis of specific anti-tau antibodies did not reflect patient disability when the group of MS patients was evaluated as a whole. Here, MAPT is linked to myeloid sarcoma.